​

Adicet Bio (ACET) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ACET Stock Forecast

Adicet Bio (ACET) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $18.00 and a low of $18.00. This represents a 106.90% increase from the last price of $8.70.

- $4 $8 $12 $16 $20 High: $18 Avg: $18 Low: $18 Last Closed Price: $8.7

ACET Stock Rating

Adicet Bio stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (75.00%), 3 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 3 9 Strong Sell Sell Hold Buy Strong Buy

ACET Price Target Upside V Benchmarks

TypeNameUpside
StockAdicet Bio106.90%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$18.00$18.00$18.00
Last Closing Price$8.70$8.70$8.70
Upside/Downside106.90%106.90%106.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-7---7
Dec, 25-7---7
Nov, 25161--8
Oct, 25161--8
Sep, 25161--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 06, 2026Canaccord Genuity$18.00$8.15120.86%106.90%
Dec 12, 2022H.C. Wainwright$38.00$17.27120.03%336.78%
Mar 04, 2022Kelly ShiJefferies$27.00$12.56114.97%210.34%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 21, 2026H.C. WainwrightBuyBuyhold
Nov 19, 2025CitigroupMarket PerformMarket Performhold
Oct 08, 2025GuggenheimBuyBuyhold
Oct 17, 2024H.C. WainwrightNeutralNeutralhold
Sep 30, 2024GuggenheimBuyupgrade
Sep 20, 2024H.C. WainwrightNeutralNeutralhold
Sep 11, 2024Piper SandlerNeutraldowngrade
Sep 11, 2024Canaccord GenuityBuyBuyhold
Sep 11, 2024H.C. WainwrightNeutraldowngrade
Nov 09, 2023WedbushOutperformOutperformhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.00$-1.63$-3.31$-1.33----
Avg Forecast$-1.91$-1.27$-3.31$-1.59$-1.64$-1.51$-1.92$-2.01
High Forecast$-1.91$-1.27$-3.02$-1.57$-0.95$-0.92$0.21$-2.01
Low Forecast$-1.91$-1.27$-3.58$-1.60$-2.95$-3.77$-5.92$-2.01
Surprise %4.71%28.35%--16.35%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.73M$24.99M------
Avg Forecast$8.18M$35.40M$555.56K$1.67M$3.33M$6.67M$42.78M$112.61M
High Forecast$8.18M$35.40M$555.56K$1.67M$3.33M$6.67M$42.78M$112.61M
Low Forecast$8.18M$35.40M$555.56K$1.67M$3.33M$6.67M$42.78M$112.61M
Surprise %18.89%-29.40%------

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.00M$-67.03M$-142.66M$-117.12M----
Avg Forecast$-82.35M$-54.47M$-142.66M$-68.19M$-126.91M$-132.96M$-103.95M$-86.52M
High Forecast$-82.35M$-54.47M$-129.82M$-67.45M$-40.68M$-39.67M$9.03M$-86.52M
Low Forecast$-82.35M$-54.47M$-154.19M$-68.93M$-126.92M$-162.34M$-254.78M$-86.52M
Surprise %-24.72%23.05%-71.76%----

ACET Forecast FAQ

Is Adicet Bio stock a buy?

Adicet Bio stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Adicet Bio is a favorable investment for most analysts.

What is Adicet Bio's price target?

Adicet Bio's price target, set by 12 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $18 at the low end to $18 at the high end, suggesting a potential 106.90% change from the previous closing price of $8.7.

How does Adicet Bio stock forecast compare to its benchmarks?

Adicet Bio's stock forecast shows a 106.90% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Adicet Bio over the past three months?

  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 12.50% Strong Buy, 75.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Adicet Bio’s EPS forecast?

Adicet Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.64, marking a 23.31% increase from the reported $-1.33 in 2024. Estimates for the following years are $-1.51 in 2026, $-1.92 in 2027, and $-2.01 in 2028.

What is Adicet Bio’s revenue forecast?

Adicet Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $3.33M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $6.67M, followed by $42.78M for 2027, and $112.62M for 2028.

What is Adicet Bio’s net income forecast?

Adicet Bio's net income forecast for the fiscal year ending in December 2025 stands at $-127M, representing an 8.36% increase from the reported $-117M in 2024. Projections indicate $-133M in 2026, $-104M in 2027, and $-86.515M in 2028.